refludan and Down-Syndrome

refludan has been researched along with Down-Syndrome* in 1 studies

Other Studies

1 other study(ies) available for refludan and Down-Syndrome

Article	Year
Progressive thrombosis in a 13-year-old girl with trisomy 21 under therapy with low molecular weight heparin. Klinische Padiatrie, 2011, Volume: 223, Issue:3 Topics: Adolescent; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Antithrombins; beta 2-Glycoprotein I; Diagnosis, Differential; Disease Progression; Dose-Response Relationship, Drug; Down Syndrome; Enoxaparin; Female; Hirudins; Humans; Immunoglobulin M; Recombinant Proteins; Renal Veins; Thrombophlebitis; Thrombosis; Vena Cava, Inferior	2011

Article

Year

Progressive thrombosis in a 13-year-old girl with trisomy 21 under therapy with low molecular weight heparin.

Klinische Padiatrie, 2011, Volume: 223, Issue:3

Topics: Adolescent; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Antithrombins; beta 2-Glycoprotein I; Diagnosis, Differential; Disease Progression; Dose-Response Relationship, Drug; Down Syndrome; Enoxaparin; Female; Hirudins; Humans; Immunoglobulin M; Recombinant Proteins; Renal Veins; Thrombophlebitis; Thrombosis; Vena Cava, Inferior

2011